Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects
Advanced Science · 15.11.2026
DOI: 10.1002/advs.78615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.11.2026. Verfasst von Le Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Scientific Research Project for High-level Health Talents of Hunan Province, Natural Science Foundation of Hunan Province, Health Commission of Hunan Province.
Abstract (Originalsprache)
Staphylococcus aureus infection impairs bone repair, but how bacterial proteins disrupt osteogenic progenitors remains unclear. The bacterial chaperone DnaK promotes glutathione peroxidase 4 (GPX4) degradation in bone marrow mesenchymal stem cells (BMSCs), accompanied by lipid peroxidation, ferroptotic injury, and impaired osteogenic differentiation. GPX4 protein turnover increases without a change in Gpx4 mRNA abundance. A candidate E3‐ligase screen identifies the C terminus of Hsc70‐interacting protein (CHIP) as a mediator of this response. Catalytically inactive CHIP attenuates DnaK‐associated K48‐linked GPX4 ubiquitination, while CHIP knockdown preserves GPX4 and osteogenic proteins in primary BMSCs. To target bacterial DnaK and host oxidative injury, a bone‐targeted deoxyribozyme (DNAzyme)–nanozyme platform (DMPA) combines a dnaK ‐targeting DNAzyme with manganese hexacyanoferrate, polydopamine, and alendronate. In infected cultures, DMPA reduces bacterial dnaK transcript and DnaK protein abundance and improves BMSC redox balance and matrix mineralization. In a mouse model of infected tibial defects, DMPA promotes bone regeneration. These findings link bacterial DnaK to host GPX4 degradation through CHIP and establish a bone‐targeted DNAzyme–nanozyme strategy that combines bacterial DnaK suppression with redox regulation to promote repair of infected bone defects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- International Research Center For Precision Medicine, Transformative Technology and Software Services, Changsha, Hunan, People's Republic of China.
ORCID-Profile: Zhe Guo, Mingxuan Xiao, Min Wang
Förderung
- Major Scientific Research Project for High-level Health Talents of Hunan Province
- Natural Science Foundation of Hunan Province
- Health Commission of Hunan Province
Zitieren
APA
Gao, L., Xi, Y., Guo, Z., Xiao, M., Wang, B., Chen, Z., Li, X., & Wang, M. (2026). Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects. Advanced Science. https://doi.org/10.1002/advs.78615
Vancouver
Gao L, Xi Y, Guo Z, Xiao M, Wang B, Chen Z, et al. Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects. Advanced Science. 2026. doi:10.1002/advs.78615
BibTeX
@article{Gao2026,
author = {Gao, Le and Xi, Yang and Guo, Zhe and Xiao, Mingxuan and Wang, Bingqi and Chen, Zhenni and Li, Xianping and Wang, Min},
title = {Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.78615}
}
EUVIMED